Your browser doesn't support javascript.
loading
Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization.
Andrews, Karen L; Sampson, Amanda K; Irvine, Jennifer C; Shihata, Waled A; Michell, Danielle L; Lumsden, Natalie G; Lim, Chloe; Huet, Olivier; Drummond, Grant R; Kemp-Harper, Barbara K; Chin-Dusting, Jaye P F.
Afiliação
  • Andrews KL; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia karen.andrews@monash.edu.
  • Sampson AK; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Irvine JC; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Shihata WA; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  • Michell DL; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Lumsden NG; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Lim C; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Huet O; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
  • Drummond GR; Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  • Kemp-Harper BK; Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  • Chin-Dusting JP; Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia Cardiovascular Disease Program and Department of Pharmacology, Biomedical Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
Clin Sci (Lond) ; 130(18): 1629-40, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27231254
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monócitos / Polaridade Celular / Aterosclerose / Células Endoteliais da Veia Umbilical Humana / Macrófagos / Óxidos de Nitrogênio Limite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monócitos / Polaridade Celular / Aterosclerose / Células Endoteliais da Veia Umbilical Humana / Macrófagos / Óxidos de Nitrogênio Limite: Animals / Humans / Male Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido